In studies on human colon cancer and lymphoma cell lines, aspirin appeared to have a direct impact on angiogenesis by both inhibiting the COX enzyme which is frequently overexpressed in cancer cells, as well as by directly modulating vascular-endothelial growth factor (VEGF) activity [14,15]. The gene discussed is VEGFA; the disease is malignant colon neoplasm.